← Back to Patent Explorer
US4276376A Expired / Lapsed US ⏱️ 0.0 years remaining

Creatine kinase control serum

Assignee: Roche Diagnostics GmbH
•
Filing: 1979-07-16
•
Granted: 1981-06-30
•
Expires: 1999-07-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Control serum containing a defined content of creatine kinase comprising exogeneous creatine kinase in the form of swine serum and optionally additionally comprising human serum, other animal serum or serum albumin; and/or other enzyme substrates and metabolites occurring in serum.

Inventors

  • 👤 Dieter Hundt
  • 👤 Marianne Sedelmeyer
  • 👤 Peter Roschlau
  • 👤 Fritz Stahler
  • 👤 Wolfgang Gruber

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 00:23
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/48; C12Q1/50

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 39 words
Control serum comprising a base serum selected from the group consisting of human serum, animal serum or serum albumin and also containing a defined activity of creatine kinase, exogeneous to said base serum, in the form of swine serum.
Claim 2
Dependent Claim 39 words
Control serum comprising a base serum selected from the group consisting of human serum, animal serum or serum albumin and also containing a defined activity of creatine kinase, exogeneous to said base serum, in the form of swine serum.
Claim 3
Dependent Claim 14 words
Control serum as claimed in claim 1 wherein said base serum is human serum.
Claim 4
Dependent Claim 16 words
Control serum as claimed in claim 1 wherein said base serum is bovine or horse serum.
Claim 5
Dependent Claim 14 words
Control serum as claimed is claim 1 wherein said base serum is serum albumin.
Claim 6
Dependent Claim 19 words
Control serum as claimed in claim 1 also comprising in said base serum other enzymes occurring in the serum.
Claim 7
Dependent Claim 21 words
Control serum as claimed in claim 1 also comprising in said base serum enzymes, substrates, and metabolites occurring in the serum.
Claim 8
Dependent Claim 28 words
Control serum as claimed in claim 1 comprising one volume part of swine serum contained in 50 to 150 volume parts of a medium for said conrol serum.
Claim 9
Dependent Claim 10 words
Control serum as claimed in claim 1 in lyophilized form.
Claim 10
Dependent Claim 17 words
Control serum as claimed in claim 8 wherein said control serum is reconstituted with an aqueous medium.

References Cited (Backward Citations)

US3639211A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-06-29 1984-12-29 1985-06-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-06-29 1988-12-29 1989-06-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-06-29 1992-12-29 1993-06-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag